Enanta (ENTA) Pharmaceuticals announced the passing of its beloved and respected longtime Chief Financial and Administrative Officer Paul J. Mellett Jr. Paul’s successful career spanned almost 50 years. Prior to joining Enanta, he was Senior Vice President and CFO of Essential Therapeutics. Before that, Paul was the CFO and Vice President of Administration at GelTex Pharmaceuticals, a publicly held biotechnology company that was acquired by Genzyme Corporation in December 2000. Paul also served as CFO of Marshall Contractors, a construction management firm specializing in the pharmaceutical, biotechnology and semiconductor industries. As previously announced, Harry R. Trout, III, and Kathleen S. Capps, CPA, have been appointed as the Company’s principal financial officer and principal accounting officer, respectively, in each case on an interim basis.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENTA:
- Enanta initiated with a Buy at WestPark Capital
- Enanta Pharmaceuticals Appoints Interim Financial Officers
- Enanta Pharmaceuticals Sues Pfizer Over Patent Infringement
- Enanta files EU patent infringement suit against Pfizer
- Enanta Pharmaceuticals: Hold Rating Amid Strategic Advances and Financial Constraints